SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001213900-19-024010
Filing Date
2019-11-19
Accepted
2019-11-19 14:33:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g1119etf_insystherap.htm SC 13G 58248
  Complete submission text file 0001213900-19-024010.txt   59748
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Subject) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87828 | Film No.: 191230614
SIC: 2834 Pharmaceutical Preparations

Mailing Address 30 MAPLE STREET SUITE 2 SUMMIT NJ 07901
Business Address 30 MAPLE STREET SUITE 2 SUMMIT NJ 07901 908-897-0513
ETF MANAGERS GROUP, LLC (Filed by) CIK: 0001645173 (see all company filings)

IRS No.: 383938178 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G